Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

Steps to manage an anaphylactic transfusion reaction and the next transfusion plan?

Anaphylactic transfusion reactions require stopping the transfusion immediately and treating the reaction right away, then planning future transfusions to prevent recurrence. The correct approach is to discontinue the blood product to remove ongoing exposure to the triggering IgA-containing donor plasma, and to treat the anaphylaxis with prompt measures such as securing the airway, supporting breathing and circulation, and giving epinephrine and fluids as needed. After stabilization, consider IgA deficiency as the underlying risk factor, since many anaphylactic transfusion reactions in this context occur in patients with anti-IgA antibodies. For future transfusions, plan to use washed red blood cells or other IgA-deficient donor products to minimize exposure to IgA and reduce the risk of another reaction. Merely continuing the transfusion or switching to saline without addressing the reaction would not treat the life-threatening event, and monitoring alone would not prevent recurrence.

Anaphylactic transfusion reactions require stopping the transfusion immediately and treating the reaction right away, then planning future transfusions to prevent recurrence. The correct approach is to discontinue the blood product to remove ongoing exposure to the triggering IgA-containing donor plasma, and to treat the anaphylaxis with prompt measures such as securing the airway, supporting breathing and circulation, and giving epinephrine and fluids as needed. After stabilization, consider IgA deficiency as the underlying risk factor, since many anaphylactic transfusion reactions in this context occur in patients with anti-IgA antibodies. For future transfusions, plan to use washed red blood cells or other IgA-deficient donor products to minimize exposure to IgA and reduce the risk of another reaction. Merely continuing the transfusion or switching to saline without addressing the reaction would not treat the life-threatening event, and monitoring alone would not prevent recurrence.